myBiometry
myBiometry develops and provides data-driven solutions for early detection of asthma and COPD exacerbations. Their fenoTRACK solution uses a non-invasive breath test to measure inflammation, enabling proactive care and preventative interventions. This empowers patients to better manage their chronic conditions and reduces healthcare burden.
Funding Round: Seed
Funding Amount: $5M
Date: 12-Nov-2024
Investors: Dexcom Ventures, CareSource Indiana, Elevate Ventures
Markets: Healthtech, Medical Devices, Diagnostics
HQ: Lowell, Massachusetts, United States
Founded: 2013
Website: https://www.mybiometry.com/
LinkedIn: https://www.linkedin.com/company/mybiometry
Twitter: https://twitter.com/mybiometry
Leave a Comment
Comments
No comments yet.